SCHEMBL4359882

SCHEMBL4359882

Cc1cc2ncc(C(=O)NC(=S)Nc3cccc(OCc4ccccc4)c3)c(C)n2n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.54
KMT2A Q03164 7/20 0.54
RAB9A P51151 4/20 0.54
POLB P06746 2/20 0.47
ALDH1A1 P00352 6/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
TDP1 Q9NUW8 2/20 0.46
LMNA P02545 2/20 0.46
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPT P10636 3/20 0.45
NPC1 O15118 4/20 0.44
ALOX12 P18054 2/20 0.44
CTSV O60911 1/20 0.43
CTSL P07711 1/20 0.43
MAPK1 P28482 1/20 0.43
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4366059 0.92 ALDH1A1 (0.46) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL4361429 0.89 ALDH1A1 (0.47) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL14096290 0.84 MEN1 (0.54) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL4366175 0.82 PRMT5 (0.42) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL2869511 0.81 RAB9A (0.62) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL4367547 0.80 MEN1 (0.59) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL4366508 0.78 KMT2A (0.60) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL14096155 0.78 MEN1 (0.59) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL14096287 0.78 MEN1 (0.61) MEN1KMT2ARAB9APOLBALDH1A1
SCHEMBL4361591 0.78 MEN1 (0.61) MEN1KMT2ARAB9APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US claimed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US claimed
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US disclosed
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US disclosed
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US disclosed
US-7094807-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2006-08-22 US disclosed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, SLC10A1 MEN1 4762/4885KMT2A 1703/4885RAB9A 2273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.